Dashboard
Manage Tickers

ANEB Anebulo Pharmaceuticals, Inc.

Nasdaq anebulo.com


$ 2.49 $ 0.08 (3.32 %)    

Tuesday, 14-Oct-2025 13:01:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 601.31 $ 6.09 (1.02 %)
DIA $ 463.68 $ 6.53 (1.43 %)
SPY $ 664.40 $ 7.11 (1.08 %)
TLT $ 90.73 $ 0.09 (0.1 %)
GLD $ 381.55 $ 3.25 (0.86 %)
$ 2.32
$ 2.41
$ 2.40 x 76
$ 2.50 x 39
$ 2.34 - $ 2.49
$ 0.80 - $ 3.42
17,205
na
95.32M
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-29-2025 06-30-2025 10-K
2 05-13-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-Q
4 11-13-2024 09-30-2024 10-Q
5 09-25-2024 06-30-2024 10-K
6 05-15-2024 03-31-2024 10-Q
7 02-13-2024 12-31-2023 10-Q
8 11-14-2023 09-30-2023 10-Q
9 09-22-2023 06-30-2023 10-K
10 05-11-2023 03-31-2023 10-Q
11 02-10-2023 12-31-2022 10-Q
12 11-10-2022 09-30-2022 10-Q
13 09-09-2022 06-30-2022 10-K
14 05-11-2022 03-31-2022 10-Q
15 02-11-2022 12-31-2021 10-Q
16 11-12-2021 09-30-2021 10-Q
17 09-22-2021 06-30-2021 10-K
18 06-21-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

anaptysbio-announces-daniel-faga-anticipated-to-be-ceo-of-biopharma-co-upon-deal-close-royalty-management-company-to-manage-royalties-including-jemperli--imsidolimab-biopharma-co-to-launch-with-adequate-capital-to-fund-operations-for-at-least-2-years
AnaptysBio Announces Daniel Faga Anticipat...
09/29/2025 20:42:28

anebulo-pharmaceuticals-q4-eps-005-beats-008-estimate
Anebulo Pharmaceuticals Q4 EPS $(0.05) Bea...
09/29/2025 20:12:44

anebulo-pharmaceuticals-doses-first-patients-in-phase-1-single-ascending-dose-study-of-intravenous-selonabant-for-acute-cannabis-induced-toxicity
Anebulo Pharmaceuticals Doses First Patien...
09/25/2025 11:33:20

deal-dispatch-need-ma-approval-fcc-chair-explains-how-to-get-it
Deal Dispatch: Need M&A Approval? FCC Chai...
09/19/2025 15:58:25

The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desper...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/12/2025 12:09:50

anebulo-pharmaceuticals-weighs-going-private-as-board-reviews-strategic-alternatives
Anebulo Pharmaceuticals Weighs Going Priva...
09/12/2025 11:32:03

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people s...

maxim-group-downgrades-anebulo-pharmaceuticals-to-hold
Maxim Group Downgrades Anebulo Pharmaceuti...
07/23/2025 21:41:37

Maxim Group analyst Michael Okunewitch downgrades Anebulo Pharmaceuticals (NASDAQ:ANEB) from Buy to Hold.

crude-oil-falls-thermo-fisher-scientific-earnings-top-views
Crude Oil Falls; Thermo Fisher Scientific ...
07/23/2025 17:18:30

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 17:06:04

dow-surges-over-200-points-att-posts-upbeat-earnings
Dow Surges Over 200 Points; AT&T Posts Upb...
07/23/2025 14:39:05

anebulo-pharmaceuticals-approves-plan-for-reverse-stock-spilt-of-not-less-than-1-for-2500-and-not-more-than-1-for-7500-as-proposed-stockholders-will-receive-350-per-pre-spilt-share
Anebulo Pharmaceuticals Approves Plan For ...
07/23/2025 12:13:40

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suff...

anebulo-pharma-proposes-reverse-stock-split-and-350-cash-out-offer-to-go-private
Anebulo Pharma Proposes Reverse Stock Spli...
07/23/2025 12:12:24

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suff...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 12:08:15

trading-halt-halt-status-updated-at-75500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:55:...
07/23/2025 11:55:05

trading-halt-halted-at-72500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:25:00 a.m. ET - ...
07/23/2025 11:25:04

maxim-group-maintains-buy-on-anebulo-pharmaceuticals-lowers-price-target-to-3
Maxim Group Maintains Buy on Anebulo Pharm...
05/15/2025 17:14:29

Maxim Group analyst Michael Okunewitch maintains Anebulo Pharmaceuticals (NASDAQ:ANEB) with a Buy and lowers the price targe...

anebulo-pharmaceuticals-q3-eps-004-beats-005-estimate
Anebulo Pharmaceuticals Q3 EPS $(0.04) Bea...
05/13/2025 22:26:23

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate ...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/27/2025 12:05:52

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/13/2025 17:06:33

anebulo-pharmaceuticals-q2-2025-gaap-eps-009-misses-008-estimate
Anebulo Pharmaceuticals Q2 2025 GAAP EPS $...
02/14/2025 21:07:27

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimat...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION